Wells Fargo’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-426,835
Closed -$3.92M 7530
2021
Q2
$3.92M Buy
426,835
+18,221
+4% +$167K ﹤0.01% 2952
2021
Q1
$2.03M Sell
408,614
-57,424
-12% -$285K ﹤0.01% 3475
2020
Q4
$2.01M Buy
466,038
+78,643
+20% +$339K ﹤0.01% 3451
2020
Q3
$1.66M Buy
387,395
+92,114
+31% +$395K ﹤0.01% 3395
2020
Q2
$1.33M Buy
295,281
+134,640
+84% +$605K ﹤0.01% 3520
2020
Q1
$643K Sell
160,641
-6,358
-4% -$25.4K ﹤0.01% 3739
2019
Q4
$1.42M Sell
166,999
-46,613
-22% -$395K ﹤0.01% 3561
2019
Q3
$1.46M Buy
213,612
+31,332
+17% +$215K ﹤0.01% 3533
2019
Q2
$1.52M Sell
182,280
-1,665
-0.9% -$13.9K ﹤0.01% 3514
2019
Q1
$1.69M Sell
183,945
-8,453
-4% -$77.5K ﹤0.01% 3471
2018
Q4
$2.11M Buy
192,398
+24,786
+15% +$271K ﹤0.01% 3176
2018
Q3
$2.34M Sell
167,612
-154,294
-48% -$2.15M ﹤0.01% 3243
2018
Q2
$3.43M Sell
321,906
-37,977
-11% -$404K ﹤0.01% 2986
2018
Q1
$3.11M Sell
359,883
-6,852
-2% -$59.3K ﹤0.01% 2980
2017
Q4
$3.47M Buy
366,735
+29,127
+9% +$275K ﹤0.01% 2883
2017
Q3
$2.65M Buy
337,608
+7,206
+2% +$56.6K ﹤0.01% 3045
2017
Q2
$2.84M Buy
330,402
+500
+0.2% +$4.3K ﹤0.01% 2885
2017
Q1
$2.33M Buy
329,902
+3,550
+1% +$25K ﹤0.01% 3046
2016
Q4
$1.39M Buy
326,352
+116,725
+56% +$496K ﹤0.01% 3398
2016
Q3
$1.05M Buy
209,627
+206,638
+6,913% +$1.03M ﹤0.01% 3399
2016
Q2
$11K Buy
2,989
+2,250
+304% +$8.28K ﹤0.01% 5365
2016
Q1
$3K Sell
739
-148,946
-100% -$605K ﹤0.01% 5714
2015
Q4
$509K Buy
149,685
+149,585
+149,585% +$509K ﹤0.01% 3814
2015
Q3
$1K Sell
100
-1,437
-93% -$14.4K ﹤0.01% 5793
2015
Q2
$10K Buy
1,537
+978
+175% +$6.36K ﹤0.01% 5576
2015
Q1
$4K Sell
559
-3,634
-87% -$26K ﹤0.01% 5640
2014
Q4
$32K Sell
4,193
-3,936
-48% -$30K ﹤0.01% 4983
2014
Q3
$75K Buy
8,129
+3,343
+70% +$30.8K ﹤0.01% 4665
2014
Q2
$90K Buy
+4,786
New +$90K ﹤0.01% 4618